WOBURN, Mass.--(BUSINESS WIRE)--BioTrove, Inc. today announced it has formed a research collaboration with Constellation Pharmaceuticals in which Constellation will utilize BioTrove’s RapidFire® Mass Spectrometry (RF-MS) system to accelerate development of novel therapeutics in the emerging field of epigenetics.
